Mark Kubler
Direktor/Vorstandsmitglied bei INFLARX N.V.
Ursprung des Netzwerks ersten Grades von Mark Kubler
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
25
| Public Company | Biotechnology | 25 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mark Kubler
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Investment Banks/Brokers | Analyst-Equity | |
| FRESENIUS SE & CO. KGAA | Medical Specialties | Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Compliance Officer Corporate Officer/Principal | |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Investment Banks/Brokers | Corporate Officer/Principal | |
| AGENUS INC. | Biotechnology | Investor Relations Contact | |
Coleman Research Corp.
 Coleman Research Corp. Engineering & ConstructionIndustrial Services Part of L3Harris Technologies, Inc., Coleman Research Corp. is a company that provides aviation and aeronautical engineering. The company is based in Orlando, FL. Coleman Research was acquired by L-3 Communications Holdings, Inc. from Thermo Electron Corp. on January 03, 2001 for $65 million. | Engineering & Construction | Corporate Officer/Principal | |
| THERATECHNOLOGIES INC. | Pharmaceuticals: Major | Director/Board Member | |
ING Financial Markets LLC
 ING Financial Markets LLC Investment Banks/BrokersFinance ING Financial Markets LLC (ING Financial) is a FINRA-registered broker/dealer headquartered in New York City. They have additional offices in Dallas, Houston and Los Angeles. The firm is a wholly-owned subsidiary of ING Financial Holdings Corp, itself a subsidiary of ING Groep NV (AMS: INGA) in The Netherlands. ING Financial offers a broad range of investment services to corporate and financial institutions, as well as other ING businesses. Their research team places a particular emphasis on emerging markets. Key product areas offered are: corporate and government debt, credit and equity derivatives, treasury products (including Repo and CP/CD issuance), interest rate derivatives, foreign exchange, structured products and securities financing. | Investment Banks/Brokers | Analyst-Equity | |
| VERACYTE, INC. | Medical Specialties | Director/Board Member | |
| MEDIGENE AG | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| MORPHOSYS AG | Biotechnology | Director of Finance/CFO | |
| University of Freiburg | College/University | Doctorate Degree Undergraduate Degree | |
Fresenius Kabi AG
 Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Fresenius ProServe GmbH
 Fresenius ProServe GmbH Hospital/Nursing ManagementHealth Services Fresenius ProServe GmbH specializes in the medical business with hospitals and healthcare facilities. Its services range from the planning and construction of hospitals to technical and operational management in its core areas of hospital management and hospital engineering. The company is headquartered in Bad Homburg vor der Höhe, Germany. | Hospital/Nursing Management | Chief Executive Officer | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| Champlain College | College/University | Undergraduate Degree | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree | |
| Tulane University (Louisiana) | College/University | Undergraduate Degree | |
| University of Michigan | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| CAMURUS AB | Pharmaceuticals: Major | Director/Board Member | |
| University of Münster | College/University | Undergraduate Degree | |
Affentranger Associates SA
 Affentranger Associates SA Investment ManagersFinance Affentranger Associates SA (aa) is an independent Swiss private equity firm which was founded in 2002 by Anton Affentranger. As principal investor, the firm aims to achieve sustainable long-term returns by combining capital and labor investments in companies in transition. Based in Geneva, aa is strategic advisor to a small group of exclusive clients with whom they seek to build long-term relationships and provide tailored entrepreneurial solutions based on objective advice. | Investment Managers | Private Equity Investor | |
| VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
InflaRx GmbH
 InflaRx GmbH BiotechnologyHealth Technology InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany. | Biotechnology | Chairman Director/Board Member Director/Board Member Founder Founder Director/Board Member Director/Board Member | |
| BIONTECH SE | Biotechnology | Director of Finance/CFO | |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Investor Relations Contact | |
Hospitalia International GmbH
 Hospitalia International GmbH Medical/Nursing ServicesHealth Services Part of Else Kröner-Fresenius-Stiftung, Hospitalia International GmbH is a German company that provides health care and other related services. The company is based in Bad Homburg, Germany. The CEOs of the company are Mirsad Midzic, Jens K. Schäkel, Rafael Garcia Feil. | Medical/Nursing Services | Corporate Officer/Principal | |
Cross Current Research LLC
 Cross Current Research LLC Investment ManagersFinance Founded in 2009 by Dr. Alex To, Cross Current Research LLC is an independent research firm located in Skillman, New Jersey. The firm offers comprehensive fundamental industry and company-specific research, as well as technical analysis of stocks and markets. They cover the healthcare, technology and financial services sectors. Cross Current Research offers services to institutional investors. | Investment Managers | Analyst-Equity | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | President | |
| ADVICENNE | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Fresenius Kabi Asia Pacific Ltd.
 Fresenius Kabi Asia Pacific Ltd. Medical DistributorsDistribution Services Part of Fresenius SE & Co. KGaA, Fresenius Kabi Asia Pacific Ltd. is a Chinese healthcare company that was founded in 2001. The company is based in Hong Kong, Hong Kong and specializes in providing lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is committed to making essential medicines and technologies accessible to healthcare professionals who help patients. | Medical Distributors | Corporate Officer/Principal | |
| MIT Sloan School of Management | College/University | Masters Business Admin | |
Sanofi AB
 Sanofi AB Medical DistributorsDistribution Services Part of Sanofi, Sanofi AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company's description states that it is an international pharmaceutical company. | Medical Distributors | Corporate Officer/Principal | |
| TERRASCEND CORP. | Agricultural Commodities/Milling | General Counsel | |
| Oslo Metropolitan University | College/University | Undergraduate Degree | |
| Ullevaal School of Bioengineering | College/University | Undergraduate Degree | |
| IMMATICS N.V. | Biotechnology | Director of Finance/CFO Investor Relations Contact | |
| Belnor BVBA | Founder | ||
| OLINK HOLDING AB | Biotechnology | Investor Relations Contact | |
| Jane Goddall Institute Belgium | Director/Board Member | ||
| Hospitalia Care Gmbh | Corporate Officer/Principal | ||
Fresenius Kabi Deutschland GmbH
 Fresenius Kabi Deutschland GmbH Pharmaceuticals: GenericHealth Technology Part of Fresenius SE & Co. KGaA, Fresenius Kabi Deutschland GmbH is a healthcare company based in Bad Homburg vor der Hohe, Germany. The CEOs are Steffen Roser, Christoph Funke, Tanja Greve. Fresenius Kabi creates an environment of mutual respect, encouragement, and teamwork. The German company specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company is also specialized in the field of oncology products supported by integrated manufacturing, regulatory, sales, marketing & distribution set up. The company has summarized their expectations towards their suppliers and business partners in a suppliers code of conduct and a business partner code of conduct. The company was founded in 1999. | Pharmaceuticals: Generic | Chief Executive Officer | |
| The Golf Championships, Inc. | Investor Relations Contact |
Statistik
International
| Vereinigte Staaten | 18 |
| Deutschland | 17 |
| Schweden | 7 |
| Kanada | 3 |
| Frankreich | 3 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 10 |
| Finance | 9 |
| Health Services | 4 |
| Distribution Services | 3 |
Operativ
| Corporate Officer/Principal | 59 |
| Director/Board Member | 58 |
| Director of Finance/CFO | 23 |
| Independent Dir/Board Member | 17 |
| Undergraduate Degree | 17 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Nicolas Fulpius | 34 |
| Thomas Taapken | 16 |
| Arnd Christ | 15 |
| Jens Holstein | 14 |
| Richard Brudnick | 13 |
| Jason Marks | 11 |
| Li Na Ma | 11 |
| Hege Hellstrom | 11 |
| Jan Medina | 11 |
| Katrin Uschmann | 11 |
| Anthony Gibney | 11 |
| Jordan Zwick | 7 |
| Niels Riedemann | 7 |
| Jordan Silverstein | 7 |
| Bruce P. Burnett | 7 |
- Börse
- Insiders
- Mark Kubler
- Unternehmensverbindungen
